Rapid Micro Biosystems (RPID) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Aehr Test Systems (AEHR) have what it takes to be a top stock pick for momentum investors? Let's find out.

U.S. dollar's pullback provided additional support to gold markets.

SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman notifies investors of the filing of a securities class action against Apollo Global Management, Inc. (NYSE: APO) following a series of investigative reports. The litigation seeks to represent investors who purchased or otherwise acquired Apollo securities between May 10, 2021, and February 21, 2026 (the “Class Period”).

SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman notifies investors in Navan, Inc. (NASDAQ: NAVN) that the deadline to move for Lead Plaintiff in the pending securities class action is April 24, 2026. REPORT YOUR NAVN INVESTMENT LOSSES TO HBSS NOW The lawsuit, McCown v.

@ProsperTradingAcademy's Mike Shorr turns to tech and the final frontier for today's Big 3. He sees trading opportunities in Cloudflare's (NET) latest stock plunge, has a bullish bias on Twilio (TWLO) into earnings, and sees AST Spacemobile's (ASTS) new pullback as a buying opportunity.

While some investors and commentators have criticized the lack of transparency and disclosure in private credit funds, Global Head of Blackstone Private Wealth Joan Solotar, says the funds often disclose more loan information than banks.

The semiconductor sector is on fire. While the broader market has spent much of 2026 navigating volatility, the VanEck Semiconductor ETF NASDAQ: SMH, the most widely followed sector benchmark, has surged over 20% year to date.

Goldman Sachs filed a Bitcoin ETF prospectus as the top cryptocurrency surged above $76,000, as broader risk assets also advanced on improving market sentiment. The move could add fresh momentum to a market already watching renewed institutional interest in crypto-linked products.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

JPMorgan Chase (NYSE:JPM | JPM Price Prediction) has raised its quarterly dividend by 7%, moving from $1.40 per share to $1.50 per share.

ASTS is ramping Block 2 BlueBird production with vertical integration to manage supply-chain risks, but reliance on outside vendors still leaves some exposure.

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) declared its 64th consecutive annual dividend increase on April 14, 2026, lifting its quarterly payout from $1.30 per share to $1.34 per share, a 3% increase.

CNBC's Seema Mody reports the latest news surrounding Oracle.

Channel checks suggest AppLovin may gain 3 to 5 points of ad budget share over the next 6 to 12 months if planned reallocations materialize. APP's current 1.3 percent ad conversion rate is low versus management's blended 5 percent target, so revenue acceleration depends on clear improvement in ad performance metrics. APP's ad conversion rate is trending better versus peers, but return on ad spend still lags other ad platforms.

SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- On March 2, 2026, investors in Aardvark Therapeutics (NASDAQ: AARD) saw the price of their shares crater $7.02 (-56%) after the company announced that it stopped its Phase 3 Hunger Elimination of Reduction Objective (“HERO”) trial evaluating the efficacy and safety of ARD-101 as a treatment for hyperphagia (insatiable hunger) in patients with Prader-Willi Syndrome (“PWS”). The development and severe market reaction have prompted national shareholder rights firm Hagens Berman to open an investigation into whether Aardvark may have misled investors in violation of federal securities laws.

T and CMCSA are making strategic moves to strengthen their telecom positions as competition heats up across broadband and wireless.

Vereigen Media's podcast series delivers real-world insights into how today's B2B marketers build scalable, high-impact growth strategies Vereigen Media's podcast series delivers real-world insights into how today's B2B marketers build scalable, high-impact growth strategies

Nebius Group N.V. is a strategic AI infrastructure asset, uniquely positioned to capitalize on surging GPU scarcity and power bottlenecks. NBIS has secured $4.3B in fresh capital, and a $27B Meta deal and is scaling data center capacity aggressively across Europe and the U.S. GPU rental prices are soaring, capacity is sold out, and Nebius's early power contracting creates a formidable competitive moat.

RICHARDSON, Texas--(BUSINESS WIRE)-- #AdvoCareRehydrate--AdvoCare International, LLC, a leading health and wellness company, is excited to announce the limited‑time release of Rehydrate: Hydration + Energy in two new refreshing flavors: Mixed Berry and Green Apple. Launched early in 2026, the product is designed for customers who want to stay sharp and fueled, and to deliver rapid hydration and steady, clean energy in one simple step. Rehydrate: Hydration + Energy combines four key electrolytes with 100mg of green.